These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7951125

  • 21. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
    Mehta J, Kelsey S, Chu P, Powles R, Hazel D, Riley U, Evans C, Newland A, Treleaven J, Singhal S.
    Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254
    [Abstract] [Full Text] [Related]

  • 22. Total intestinal decontamination for prevention of infection in bone marrow transplantation.
    Funada H, Teshima H, Hattori K.
    Jpn J Clin Oncol; 1983 Jul; 13 Suppl 1():111-26. PubMed ID: 6339774
    [Abstract] [Full Text] [Related]

  • 23. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albós A.
    Haematologica; 1997 Jul; 82(3):297-304. PubMed ID: 9234575
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD, Dodds Ashley ES, Addison RM, Alspaugh JA, Chao NJ, Perfect JR.
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [Abstract] [Full Text] [Related]

  • 30. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.
    Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N.
    Clin Infect Dis; 1999 Feb; 28(2):331-40. PubMed ID: 10064252
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Infection in the bone marrow transplant recipient.
    Walter EA, Bowden RA.
    Infect Dis Clin North Am; 1995 Dec; 9(4):823-47. PubMed ID: 8747768
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
    Mattiuzzi GN, Kantarjian H, Faderl S, Lim J, Kontoyiannis D, Thomas D, Wierda W, Raad I, Garcia-Manero G, Zhou X, Ferrajoli A, Bekele N, Estey E.
    Cancer; 2004 Feb 01; 100(3):581-9. PubMed ID: 14745876
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
    Rosenthal J, Sender L, Secola R, Killen R, Millerick M, Murphy L, Cairo MS.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):185-91. PubMed ID: 8832013
    [Abstract] [Full Text] [Related]

  • 40. Germ monitoring of patients, staff and environment in reverse isolation.
    Hoffmann FA, Mittelstedt B, Kubel M, Helbig W.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Jul 01; 116(3-4):577-80. PubMed ID: 2480311
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.